Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News3D vascularized pancreatic adenocarcinoma tissue was microengineered in a tri-culture system composed of patient-derived pancreatic organoids, human fibroblasts, and endothelial cells on a perfusable platform, situated in a 96-well plate.
[Advanced Functional Materials]
6445212 Z89HCR5P items 1 apa 0 default asc 1 163173 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-61d823b456ac602c34b645fc49d5eb0b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Z89HCR5P%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nakagami%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENakagami%2C%20H.%2C%20Hayashi%2C%20H.%2C%20Shimamura%2C%20M.%2C%20Rakugi%2C%20H.%2C%20%26amp%3B%20Morishita%2C%20R.%20%282021%29.%20Therapeutic%20vaccine%20for%20chronic%20diseases%20after%20the%20COVID-19%20Era.%20%3Ci%3EHypertension%20Research%3C%5C%2Fi%3E%2C%201%26%23x2013%3B7.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41440-021-00677-3%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41440-021-00677-3%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DZ89HCR5P%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Therapeutic%20vaccine%20for%20chronic%20diseases%20after%20the%20COVID-19%20Era%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hironori%22%2C%22lastName%22%3A%22Nakagami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroki%22%2C%22lastName%22%3A%22Hayashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Munehisa%22%2C%22lastName%22%3A%22Shimamura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiromi%22%2C%22lastName%22%3A%22Rakugi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryuichi%22%2C%22lastName%22%3A%22Morishita%22%7D%5D%2C%22abstractNote%22%3A%22There%20is%20currently%20a%20respiratory%20disease%20outbreak%20caused%20by%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20%28SARS-CoV-2%29.%20After%20rapid%20development%2C%20RNA%20vaccines%20and%20adenoviral%20vector%20vaccines%20were%20approved%20within%20a%20year%2C%20which%20has%20demonstrated%20the%20strong%20impact%20of%20preventing%20infectious%20diseases%20using%20gene%20therapy%20technology.%20Furthermore%2C%20intensive%20immunological%20analysis%20has%20been%20performed%20to%20evaluate%20the%20efficiency%20and%20safety%20of%20these%20vaccines%2C%20potentially%20allowing%20for%20rapid%20progress%20in%20vaccine%20technology.%20After%20the%20coronavirus%20disease%202019%20%28COVID-19%29%20era%2C%20the%20novel%20vaccine%20technology%20developed%20will%20expand%20to%20other%20vaccines.%20We%20have%20been%20developing%20vaccines%20for%20chronic%20diseases%2C%20such%20as%20hypertension%2C%20for%20%3E10%20years.%20Regarding%20the%20development%20of%20vaccines%20against%20self-antigens%20%28i.e.%2C%20angiotensin%20II%29%2C%20the%20vaccine%20should%20efficiently%20induce%20a%20blocking%20antibody%20response%20against%20the%20self-antigen%20without%20activating%20cytotoxic%20T%20cells.%20Therefore%2C%20the%20epitope%20vaccine%20approach%20has%20been%20proposed%20to%20induce%20antibody%20production%20in%20response%20to%20a%20combination%20of%20a%20B%20cell%20epitope%20and%20exogenous%20T%20cell%20epitopes%20through%20major%20histocompatibility%20complex%20molecules.%20When%20these%20vaccines%20are%20established%20as%20therapeutic%20options%20for%20hypertension%2C%20their%20administration%20regimen%2C%20which%20might%20be%20a%20few%20times%20per%20year%2C%20will%20replace%20daily%20medication%20use.%20Thus%2C%20therapeutic%20vaccines%20for%20hypertension%20may%20be%20a%20novel%20option%20to%20control%20the%20progression%20of%20cerebrovascular%20diseases.%20Hopefully%2C%20the%20accumulation%20of%20immunological%20findings%20and%20vaccine%20technology%20advances%20due%20to%20COVID-19%20will%20provide%20a%20novel%20concept%20for%20vaccines%20for%20chronic%20diseases.%22%2C%22date%22%3A%222021-06-08%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41440-021-00677-3%22%2C%22ISSN%22%3A%221348-4214%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41440-021-00677-3%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-08T16%3A20%3A41Z%22%7D%7D%5D%7D
Nakagami, H., Hayashi, H., Shimamura, M., Rakugi, H., & Morishita, R. (2021). Therapeutic vaccine for chronic diseases after the COVID-19 Era. Hypertension Research, 1–7. https://doi.org/10.1038/s41440-021-00677-3 Cite
